Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer.
about
The epidemiology of sarcomaRadiotherapy for localised Ewing’s sarcoma in childrenA review of dosimetry studies on external-beam radiation treatment with respect to second cancer inductionAdult Wilms' tumor - diagnosis and current therapySecond solid cancers after radiation therapy: a systematic review of the epidemiologic studies of the radiation dose-response relationshipIonising radiation and cancer risks: what have we learned from epidemiology?Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplicationPatterns of bone sarcomas as a second malignancy in relation to radiotherapy in adulthood and histologic type.Role of chemotherapy alone or in combination with hyperthermia in the primary treatment of intraocular retinoblastoma: preliminary resultsIncidence and survival of malignant bone sarcomas in England 1979-2007.Late effects of treatment for wilms tumorDeveloping strategies for long term follow up of survivors of childhood cancerEwing's Sarcoma and Second MalignanciesRisk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapyMethodological extensions of meta-analysis with excess relative risk estimates: application to risk of second malignant neoplasms among childhood cancer survivors treated with radiotherapy.Sarcomas in hereditary retinoblastomaSecondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study.Epidemiology and therapies for metastatic sarcomaNon-endocrine late complications of bone marrow transplantation in childhood: part II.Assessment of uncertainties in radiation-induced cancer risk predictions at clinically relevant doses.Second cancers in survivors of childhood cancer.The role of the replication licensing system in cell proliferation and cancer.Chemotherapy and thyroid cancer risk: a report from the childhood cancer survivor study.Variation of second cancer risk by family history of retinoblastoma among long-term survivors.Long-term adverse outcomes in survivors of childhood bone sarcoma: the British Childhood Cancer Survivor Study.Parental stress when caring for a child with cancer in Jordan: a cross-sectional survey.Risk factors associated with secondary sarcomas in childhood cancer survivors: a report from the childhood cancer survivor study.Twenty-five year follow-up of childhood Wilms tumor: a report from the Childhood Cancer Survivor StudySarcoma risk after radiation exposure.Case-parent analysis of variation in pubertal hormone genes and pediatric osteosarcoma: a Children's Oncology Group (COG) study.Melanoma in immunosuppressed patientsCause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor StudyA study of soft tissue sarcomas after childhood cancer in BritainSecond malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatmentOsteosarcoma and acromegaly: a case report and review of the literature.Childhood leukaemia: long-term excess mortality and the proportion 'cured'.Radiation-Induced Sarcoma: A 15-Year Experience in a Single Large Tertiary Referral Center.Incidence, risk factors, and pathogenesis of second malignancies in patients with non-Hodgkin lymphoma.Secondary Malignant Neoplasms Following Haematopoietic Stem Cell Transplantation in ChildhoodOsteoradionecrosis and radiation induced bone tumors following orthovoltage radiation therapy in dogs.
P2860
Q21195878-9781191A-293D-41ED-96D3-9D50EF983B7CQ24194874-778813E8-0DFE-40BD-849E-5CB0B4323E5AQ24567501-EAC4430C-1F82-446A-BF48-AB6F9AB4074BQ26852264-22464765-9EF0-4DE9-99FC-F99D477BA8C5Q26996120-F3C3E48E-0E97-43E1-8DCB-DD6CEC9E3D59Q28395078-F1F7AEC2-9332-4BFC-AA72-180C18039E9AQ28611456-125D1948-29AA-47D0-BACB-08EC5A09A8BDQ30528194-A3282AF8-E66A-4154-A81C-59531456D38FQ31918317-3D43F697-914F-44EF-ADBE-86CAE343F94EQ33274226-CAD61E6E-E6C7-4626-9B3F-533E7FE1A139Q33691101-983BF738-4742-49E2-A6F5-543D3A23F29EQ33806580-DFDF5CE6-4078-4DF1-A386-303B45822465Q34215135-E7ED6E0B-8988-4A8F-AF74-704A19E318FFQ34260518-80E6F4F8-FBB1-4094-9DA5-7A549BB79607Q34366619-725DD502-8ED8-41DB-B307-C624913AFC4FQ34433701-B307D5B3-24D3-4033-A63D-F68486AF8148Q34575967-7D7D7AFF-A27B-40EB-897E-0A1B7D8CA027Q34652142-528170F6-F2A8-4812-87B9-4A1CDAB24F63Q34722701-B3BBC0CC-8222-48D8-95FC-DA7FF0416980Q34744993-115DB1CB-8D9B-49E3-8294-174F993D1082Q35084794-707EBCB4-354C-402C-AD79-1855B223D174Q35573686-67DD7921-7202-4783-A955-DB7A9E90021FQ35661353-44601C29-E958-4051-A684-B60828B640B6Q35925143-EE59D74A-5258-44A4-9B42-BFA7A00EE26AQ36086856-5649E01C-6545-4C77-8FFB-32E3137946C3Q36156608-9A886E37-E892-4B65-8A92-0C58550B5CE8Q36176997-0614076F-660F-45E7-9814-DD8FE76D6FC8Q36252754-D5AF84BB-ED76-435B-8E7E-B47DEE3B2740Q36427460-7FCCC0BB-143A-4DDE-AA2E-E87126BD1390Q36429557-86449A4F-B4C5-4F95-B825-0F45C4964616Q36512842-E001CDD9-40D6-40E8-9640-B64B6AF348DBQ36528733-8DED21B4-FF79-4292-A306-02B6FDBDC7CAQ36611058-0D47E62A-9218-4FBC-BEB5-AC7BEF0B8A5DQ36619454-8260517B-671C-4669-96FC-FA04E0561BDDQ36720803-A0593FAE-FDBB-44E7-8A59-4291D8874CE6Q36755145-AE3771DE-AD76-4F66-807D-7036007AAF1DQ36832123-C5043CB9-16FF-46EE-B120-F579804B1249Q36911493-D8FF9DC2-BF24-4115-8FC8-2DE59BEC0F9DQ37055896-C2AE0D19-2180-4492-961B-CE445CB6B015Q37140882-5B48D3FB-27D3-43CF-B9F9-215FD05D1CDF
P2860
Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer.
@en
type
label
Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer.
@en
prefLabel
Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer.
@en
P2093
P356
P1476
Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer.
@en
P2093
Hawkins MM
Marsden HB
Stovall MA
P304
P356
10.1093/JNCI/88.5.270
P407
P577
1996-03-01T00:00:00Z